Clinical Trial Update: Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 investigator-initiated study evaluating imipramine hydrochloride in combination with lomustine for recurrent glioblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Imipramine hydrochloride (Imipramine hydrochloride)
• Lomustine (Lomustine)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING